Published August 29, 2011 | Version Accepted Version + Supplemental Material
Journal Article Open

Total Syntheses of Cyanthiwigins B, F, and G

Abstract

A concise and versatile approach toward the preparation of the cyanthiwigin family of cyathane natural products is described. By leveraging a unique double asymmetric catalytic alkylation procedure it is possible to quickly establish two of the most critical stereocenters of the cyanthiwigin framework with high levels of selectivity and expediency. The synthetic route additionally employs both a tandem ring-closing cross-metathesis reaction, and an aldehyde-olefin radical cyclization process, in order to rapidly arrive at the tricyclic cyathane core of the cyanthiwigin molecules. From this unifying intermediate, the preparations of cyanthiwigins B, F, and G are attained swiftly and without the need for protecting groups.

Additional Information

© 2011 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim. Received: February 8, 2011; Published online: July 18, 2011. This publication is based on work supported by Award No. KUS-11-006-02, made by King Abdullah University of Science and Technology (KAUST). The authors wish to thank NIH-NIGMS (R01M080269-01), Amgen, Abbott, Boehringer Ingelheim, Merck, and Bristol-Myers Squibbs, GlaxoSmithKline, Johnson and Johnson, Amgen, Merck Research Laboratories, Pfizer, Novartis, Roche, Abbott Laboratories, Boehringer-Ingelheim, AstraZeneca, and Caltech for financial support. We also wish to thank Dr. M. W. Day and Mr. L. M. Henling for X-ray crystallographic expertise, Dr. Andrew Harned, Dr. David White, Daniel Caspi, and J. T. Mohr for helpful discussions, and Professor Mark T. Hamann for authentic samples and spectra of cyanthiwigins B, F, and G. Ruthenium olefin metathesis catalysts were generously donated by Materia.

Attached Files

Accepted Version - nihms-377537.pdf

Supplemental Material - chem_201100425_sm_miscellaneous_information.pdf

Files

chem_201100425_sm_miscellaneous_information.pdf

Files (32.5 MB)

Name Size
md5:b75f286023220dc7f92daf13222b958e
31.0 MB Preview Download
md5:3816e2b02d3b9a2023be06767c7a27ec
1.6 MB Preview Download

Additional details

Identifiers

PMCID
PMC3365662
Eprint ID
27654
Resolver ID
CaltechAUTHORS:20111107-115520974

Funding

King Abdullah University of Science and Technology (KAUST)
KUS-11-006- 02
NIH
R01M080269-01
Amgen
Abbott
Boehringer Ingelheim
Merck
Bristol-Myers Squibbs
GlaxoSmithKline
Johnson and Johnson
Pfizer
Novartis
Roche
AstraZeneca
Caltech

Dates

Created
2011-11-07
Created from EPrint's datestamp field
Updated
2021-11-09
Created from EPrint's last_modified field